pentobarbital will decrease the level or effect of lorlatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.pentobarbital and olopatadine intranasal each enhance sedation. Avoid or Use Alternate Drug. Coadministration will increase possibility of CNS despair, which can lead to additive impairment of psychomotor functionality and induce d